Literature DB >> 2049248

Caffeine renal clearance and urine caffeine concentrations during steady state dosing. Implications for monitoring caffeine intake during sports events.

D J Birkett1, J O Miners.   

Abstract

1. Relationships between the plasma and urine concentrations and clearances of caffeine over successive dosage intervals at steady-state were investigated in six healthy volunteers administered caffeine, 150 mg 8 hourly for 6 days. 2. There was marked inter-individual variability in the urine (15.9-fold range) and steady-state plasma (8.1-fold range) concentrations of caffeine. 3. Urine caffeine concentrations were similar to those in plasma, with mean ratios (plasma:urine) ranging from 1.10 to 1.74. There was a good correlation (r = 0.93, P less than 0.01) between caffeine urine and plasma concentrations. 4. There was a good correlation between caffeine renal clearance and urine flow rate (r = 0.89, P less than 0.01). Caffeine renal clearance was not significantly different from the product of fu and urine flow rate, where fu is the fraction of caffeine unbound in plasma. Urine caffeine concentration and urine flow rate were not correlated (r = 0.14, P greater than 0.05). 5. The results indicate that caffeine is reabsorbed from the renal tubule to equilibrium with unbound caffeine in plasma. 6. A regulatory urine caffeine concentration limit of 12 mg 1(-1) may be exceeded by some individuals with coffee intake in the range 3 to 6 cups per day.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2049248      PMCID: PMC1368325          DOI: 10.1111/j.1365-2125.1991.tb05553.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  10 in total

1.  Caffeine content of beverages as consumed.

Authors:  R M Gilbert; J A Marshman; M Schwieder; R Berg
Journal:  Can Med Assoc J       Date:  1976-02-07       Impact factor: 8.262

2.  The simultaneous determination of theophylline, theobromine and caffeine in plasma by high performance liquid chromatography.

Authors:  T Foenander; D J Birkett; J O Miners; L M Wing
Journal:  Clin Biochem       Date:  1980-06       Impact factor: 3.281

3.  Effect of smoking on caffeine clearance.

Authors:  W D Parsons; A H Neims
Journal:  Clin Pharmacol Ther       Date:  1978-07       Impact factor: 6.875

4.  Caffeine disposition after oral doses.

Authors:  M Bonati; R Latini; F Galletti; J F Young; G Tognoni; S Garattini
Journal:  Clin Pharmacol Ther       Date:  1982-07       Impact factor: 6.875

5.  Plasma and salivary pharmacokinetics of caffeine in man.

Authors:  R Newton; L J Broughton; M J Lind; P J Morrison; H J Rogers; I D Bradbrook
Journal:  Eur J Clin Pharmacol       Date:  1981       Impact factor: 2.953

6.  Assessment of caffeine exposure: caffeine content of beverages, caffeine intake, and plasma concentrations of methylxanthines.

Authors:  A Lelo; J O Miners; R Robson; D J Birkett
Journal:  Clin Pharmacol Ther       Date:  1986-01       Impact factor: 6.875

7.  Disposition of caffeine and its metabolites in man.

Authors:  D D Tang-Liu; R L Williams; S Riegelman
Journal:  J Pharmacol Exp Ther       Date:  1983-01       Impact factor: 4.030

8.  Effects of cimetidine on caffeine disposition in smokers and nonsmokers.

Authors:  D C May; C H Jarboe; A B VanBakel; W M Williams
Journal:  Clin Pharmacol Ther       Date:  1982-05       Impact factor: 6.875

9.  Quantitative assessment of caffeine partial clearances in man.

Authors:  A Lelo; J O Miners; R A Robson; D J Birkett
Journal:  Br J Clin Pharmacol       Date:  1986-08       Impact factor: 4.335

10.  Comparative pharmacokinetics of caffeine and its primary demethylated metabolites paraxanthine, theobromine and theophylline in man.

Authors:  A Lelo; D J Birkett; R A Robson; J O Miners
Journal:  Br J Clin Pharmacol       Date:  1986-08       Impact factor: 4.335

  10 in total
  15 in total

1.  Perturbation of paracetamol urinary metabolic ratios by urine flow rate.

Authors:  J O Miners; N J Osborne; A L Tonkin; D J Birkett
Journal:  Br J Clin Pharmacol       Date:  1992-10       Impact factor: 4.335

2.  Normalized diurnal and between-day trends in illicit and legal drug loads that account for changes in population.

Authors:  Alex J Brewer; Christoph Ort; Caleb J Banta-Green; Jean-Daniel Berset; Jennifer A Field
Journal:  Environ Sci Technol       Date:  2012-07-17       Impact factor: 9.028

Review 3.  International society of sports nutrition position stand: caffeine and exercise performance.

Authors:  Nanci S Guest; Trisha A VanDusseldorp; Michael T Nelson; Jozo Grgic; Brad J Schoenfeld; Nathaniel D M Jenkins; Shawn M Arent; Jose Antonio; Jeffrey R Stout; Eric T Trexler; Abbie E Smith-Ryan; Erica R Goldstein; Douglas S Kalman; Bill I Campbell
Journal:  J Int Soc Sports Nutr       Date:  2021-01-02       Impact factor: 5.150

Review 4.  Clinically significant pharmacokinetic interactions between dietary caffeine and medications.

Authors:  J A Carrillo; J Benitez
Journal:  Clin Pharmacokinet       Date:  2000-08       Impact factor: 6.447

5.  Prediction of the clearance of eleven drugs and associated variability in neonates, infants and children.

Authors:  Trevor N Johnson; Amin Rostami-Hodjegan; Geoffrey T Tucker
Journal:  Clin Pharmacokinet       Date:  2006       Impact factor: 6.447

6.  Determination of dose-dependent absorption of amoxycillin from urinary excretion data in healthy subjects.

Authors:  S Chulavatnatol; B G Charles
Journal:  Br J Clin Pharmacol       Date:  1994-09       Impact factor: 4.335

7.  Data-driven personalization of a physiologically based pharmacokinetic model for caffeine: A systematic assessment.

Authors:  Rebekka Fendt; Ute Hofmann; Annika R P Schneider; Elke Schaeffeler; Rolf Burghaus; Ali Yilmaz; Lars Mathias Blank; Reinhold Kerb; Jörg Lippert; Jan-Frederik Schlender; Matthias Schwab; Lars Kuepfer
Journal:  CPT Pharmacometrics Syst Pharmacol       Date:  2021-06-26

8.  Development of a physiologically-based pharmacokinetic model of the rat central nervous system.

Authors:  Raj K Singh Badhan; Marylore Chenel; Jeffrey I Penny
Journal:  Pharmaceutics       Date:  2014-03-18       Impact factor: 6.321

9.  Novel minimal physiologically-based model for the prediction of passive tubular reabsorption and renal excretion clearance.

Authors:  Daniel Scotcher; Christopher Jones; Amin Rostami-Hodjegan; Aleksandra Galetin
Journal:  Eur J Pharm Sci       Date:  2016-03-28       Impact factor: 4.384

10.  Effects of urine composition on epithelial Na+ channel-targeted protease activity.

Authors:  Jonathan M Berman; Ryan G Awayda; Mouhamed S Awayda
Journal:  Physiol Rep       Date:  2015-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.